Articles from Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate Cancer—What You Should Know. This groundbreaking resource gives patients and families the tools they need to understand and talk with their healthcare providers about genetic tests that are widely recommended to guide treatment decisions, but greatly underutilized in clinical practice.

The Prostate Cancer Foundation (PCF) celebrated groundbreaking progress and innovation in the fight against prostate cancer at its 32nd Annual PCF Scientific Retreat, held October 23-25, 2025, in Carlsbad, California. The Scientific Retreat, the world’s foremost conference on prostate cancer biology and treatment, stands out each year for the variety, novelty, and impact of topics covered and the diversity and excellence of invited scientists. This annual meeting reflects PCF’s unwavering commitment to ending death and suffering from prostate cancer, a disease that affects 1 in 8 men in his lifetime (a rate similar to breast cancer) and causes nearly 36,000 deaths per year in the U.S. alone.

The Prostate Cancer Foundation (PCF) today announced the first-ever recipient of the PCF Women in Science Lifetime Achievement Award, Maha Hussain, MD, FACP, FASCO, the Genevieve Teuton Professor of Medicine at Northwestern University Feinberg School of Medicine and Deputy Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Lurie Cancer Center). Dr. Hussain will receive the award and give an honorary lecture on Friday, October 24, during the 32nd Annual Prostate Cancer Foundation Scientific Retreat, held October 23-25, 2025, in Carlsbad, California.

This Prostate Cancer Awareness Month (PCAM), the Prostate Cancer Foundation (PCF) is calling on men to get screened with a simple blood test – the prostate-specific antigen (PSA) test – that has the power to save their lives. When detected early, prostate cancer is 99% curable, yet far too many men are being diagnosed at later stages when treatment options are limited and survival rates decline.

The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and support for PCF’s 2025 Young Investigator Award program to advance important prostate cancer research among early-career physicians and scientists.

The Prostate Cancer Foundation (PCF) has commenced the 30th season of the Home Run Challenge (HRC), a historic initiative that has raised over $72 million for prostate cancer research since its inception in 1996, contributing to the more than $1 billion in PCF funding since it was founded. This year, PCF will host HRC tour stops and awareness days at professional baseball stadiums across the country to raise awareness about prostate cancer, the second most common cancer in men, as well as funds to support the development of life-saving treatments.

The Prostate Cancer Foundation (PCF) announced that its 2024 Young Investigator program has awarded a total of $6.3 million in funding to 30 promising next-generation researchers conducting innovative prostate cancer research. The PCF program, now in its 27th year, offers career and project support for early-career physicians and scientists who have demonstrated commitment to advancing the prostate cancer field.